|
Exchange Received Time  26/11/2019 10:56:07 Exchange Disseminated Time 26/11/2019 10:56:14 Time Taken 00:00:07 | With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Silodosin Capsules, 4 mg and 8 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. |
|
|